🔎 Trials Near Me

Hjem › Ulcerøs colitis › Florida › Orlando

Ulcerøs colitis kliniske forsøg i Orlando, FL

22 studier for Ulcerøs colitis søger deltagere på steder i og omkring Orlando (inden for ca. 30 miles). Åbn et studie for at se, hvem der kan deltage, og hvordan man kontakter studieteamet.

Officiel studietekst (engelsk)

Rekrutterer til et studie her? Få det vist øverst på siden — $99 i 30 dage →

Study of Advanced Therapies for the Treatment of Adult Participants With Moderately to Severely Active Crohn's Disease or Ulcerative Colitis

RekruttererFase 2
  • Digestive And Liver Center Of Florida - Orlando /ID# 280924, Orlando
  • Clinical Research of Osceola /ID# 280593, Kissimmee · 16 mi væk
Alder 18 til 75 · Alle køn · Opdateret 2. okt. 2026 · NCT07697456

A Study of Vedolizumab in Adults With Ulcerative Colitis (UC) or Crohn's Disease (CD) in the Community Setting

RekruttererFase 4
  • Endoscopic Research, Inc., Orlando
  • Orlando Health-Orlando Regional Medical Center, Orlando
  • Digestive and Liver Center of Florida, P.A., Kissimmee · 16 mi væk
Alder 18 til 80 · Alle køn · Opdateret 30. sep. 2026 · NCT06581328

Confirmatory Clinical Study in Active Ulcerative Colitis

RekruttererFase 2
  • Orlando Gastroenterology, P.A., Orlando
Alder 16 og opefter · Alle køn · Opdateret 30. sep. 2026 · NCT07296315

A Study of Eltrekibart and Mirikizumab in Adult Patients With Moderately to Severely Active Ulcerative Colitis

RekruttererFase 2
  • Orlando Health Digestive Health Institute, Orlando
  • AdventHealth Orlando, Orlando
  • Novum Research, LLC, Clermont · 24 mi væk
Alder 18 til 75 · Alle køn · Opdateret 30. sep. 2026 · NCT06598943

Study of XmAb942 in Healthy Participants and Participants With Ulcerative Colitis

RekruttererFase 1/2Frivillige med god helbredstilstand velkomne
  • Xencor Investigative Site, Kissimmee · 16 mi væk
Alder 18 til 75 · Alle køn · Opdateret 29. sep. 2026 · NCT06619990

A Study of Long-acting Antibodies Alone and in Combinations for Moderate to Severe Ulcerative Colitis

RekruttererFase 2
  • Site 007, Kissimmee · 16 mi væk
Alder 18 til 75 · Alle køn · Opdateret 29. sep. 2026 · NCT07012395

A Trial to Investigate PALI-2108 Versus Placebo in Participants With Moderately to Severely Active Ulcerative Colitis

RekruttererFase 2
  • Site US-026, Orlando
Alder 18 til 75 · Alle køn · Opdateret 29. sep. 2026 · NCT07845487

A Study to Evaluate Efficacy and Safety of MK-8690 in Participants With Moderately to Severely Active Ulcerative Colitis (MK-8690-002)

RekruttererFase 2
  • AdventHealth Orlando ( Site 1074), Orlando
Alder 18 til 75 · Alle køn · Opdateret 28. sep. 2026 · NCT07463183

A Study to Evaluate the Efficacy, Safety, and Pharmacokinetics (PK) of RO7837195 in Participants With Moderately to Severely Active Ulcerative Colitis (UC)

RekruttererFase 2
  • Clinical Research of Osceola, LLC, Kissimmee · 16 mi væk
Alder 18 og opefter · Alle køn · Opdateret 28. sep. 2026 · NCT06979336

Mirikizumab Administered at the Same Time as Tirzepatide in Adult Participants With Moderately to Severely Active Ulcerative Colitis and Obesity or Overweight: Phase 3b Study

RekruttererFase 3
  • Orlando Health, Orlando
  • Digestive and Liver Center of Florida, Orlando
Alder 18 til 70 · Alle køn · Opdateret 24. sep. 2026 · NCT06937086

LY4268989 (MORF-057) Co-Administered With Mirikizumab in Adults With Moderately to Severely Active Ulcerative Colitis:

RekruttererFase 2
  • Digestive and Liver Center of Florida, Orlando
  • Clinical Research of Osceola, Kissimmee · 16 mi væk
Alder 18 til 80 · Alle køn · Opdateret 22. sep. 2026 · NCT07186101

LY4268989 in Adults With Moderately to Severely Active Ulcerative Colitis

RekruttererFase 2
  • AdventHealth Orlando, Orlando
  • Clinical Research of Osceola, Kissimmee · 16 mi væk
Alder 18 til 80 · Alle køn · Opdateret 22. sep. 2026 · NCT07415044

A Study of Vedolizumab With Tofacitinib in Adults With Ulcerative Colitis (UC)

RekruttererFase 4
  • Endoscopic Research Inc, Orlando
Alder 18 til 65 · Alle køn · Opdateret 21. sep. 2026 · NCT06095128

A Maintenance Study to Investigate the Efficacy and Safety of Duvakitug in Participants With Moderately to Severely Active Ulcerative Colitis

RekruttererFase 3
  • Clinical Research of Osceola - Site Number: 8400013, Kissimmee · 16 mi væk
Alder 16 til 80 · Alle køn · Opdateret 15. sep. 2026 · NCT07185009

A Study to Test Whether BI 3032950 Helps People With Ulcerative Colitis

RekruttererFase 2
  • Primary Care of Osceola, Kissimmee · 16 mi væk
Alder 18 til 80 · Alle køn · Opdateret 21. aug. 2026 · NCT06636656

An Induction Study to Investigate the Efficacy and Safety of Duvakitug in Participants With Moderately to Severely Active Ulcerative Colitis

RekruttererFase 3
  • Orlando Health, Inc. - Site Number: 8400084, Orlando
  • AdventHealth Orlando - Site Number: 8400070, Orlando
  • Clinical Research of Osceola - Site Number: 8400013, Kissimmee · 16 mi væk
  • og 1 flere
Alder 16 til 80 · Alle køn · Opdateret 20. aug. 2026 · NCT07184996

Treat-to-Target of Endoscopic Remission in Patients With IBD in Symptomatic Remission

Rekrutterer
  • Advent Health, Orlando
Alder 18 og opefter · Alle køn · Opdateret 7. aug. 2026 · NCT05230173

Zymfentra (Infliximab-dyyb) REal World Cohort STudy

RekruttererObservationsstudie
  • AdventHealth, Orlando
Alder 18 og opefter · Alle køn · Opdateret 5. aug. 2026 · NCT07237516

An Observational Study of Etrasimod in Adult Patients With Moderate to Severe Ulcerative Colitis

RekruttererObservationsstudie
  • Orlando Health/Digestive Health Institute, Orlando
  • Digestive and Liver Center of Florida Kissimmee, Kissimmee · 16 mi væk
Alder 18 til 64 · Alle køn · Opdateret 9. jul. 2026 · NCT06398626

A Study to Evaluate Etrasimod Treatment in Adolescents With Ulcerative Colitis

RekruttererFase 2
  • Arnold Palmer Hospital - Center for Digestive Health and Nutrition, Orlando
Alder 12 til 17 · Alle køn · Opdateret 8. jul. 2026 · NCT05287126

A Phase 2 Study to Evaluate Therapies for Inflammatory Bowel Disease

RekruttererFase 2
  • Mirador Therapeutics Selected Site, Orlando
Alder 18 til 80 · Alle køn · Opdateret 12. mar. 2026 · NCT07113522

Hyperbaric Oxygen Therapy for Ulcerative Colitis (HBOT-UC)

Rekrutterer
  • Orlando Health, Orlando
Alder 18 til 85 · Alle køn · Opdateret 8. jan. 2026 · NCT05987852

Ulcerøs colitis forsøg i andre byer

Andre studier i Orlando

Fra ClinicalTrials.gov, data hentet 3. okt. 2026. Hver studie har sine egne kvalifikationskrav; studieteamet afgør, hvem der kan deltage.